George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.514
Bid: 1.518
Ask: 1.528
Change: 0.002 (0.13%)
Spread: 0.01 (0.659%)
Open: 1.52
High: 1.53
Low: 1.51
Prev. Close: 1.512
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter 2022 Results (Separate)

4 Nov 2022 07:00

RNS Number : 2910F
Commercial Intnl Bank (Egypt) SAE
04 November 2022
 

 

 

Commercial International Bank (Egypt) S.A.E.

Condensed Separate Financial Statements

September 30, 2022

Click on, or paste the following link into your web browser, to view the associated PDF document

http://www.rns-pdf.londonstockexchange.com/rns/2910F_1-2022-11-3.pdf

 

 

Condensed Separate Interim Statement of Financial Position as at September 30, 2022

 

 

Notes

Sep. 30, 2022

 

Dec. 31, 2021

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

Assets

 

 

 

 

Cash and balances at the central bank

8

43,776,754

 

43,385,222

 

Due from banks

9

90,378,194

 

79,991,287

 

Loans and advances to banks, net

11

1,944,633

 

312,216

 

Loans and advances to customers, net

12

176,669,649

 

144,765,808

 

Derivative financial instruments

 

951,214

 

225,376

 

Investments

 

 

 

- Financial Assets at Fair Value through P&L

13

-

 

240,987

 

- Financial Assets at Fair Value through OCI

13

230,060,807

 

192,390,931

 

- Financial Assets at Amortized cost

13

32,306,835

 

20,318,767

 

- Investments in associates and subsidiaries

14

1,074,250

 

1,014,350

 

Other assets

15

10,167,659

 

11,141,917

 

Deferred tax assets (Liabilities)

 

727,276

 

460,026

 

Property and equipment

16

2,302,530

 

2,404,237

 

Total assets

 

590,359,801

 

496,651,124

 

Liabilities and equity

 

 

 

Liabilities

 

 

 

Due to banks

17

1,703,884

 

862,759

 

Due to customers

18

497,584,590

 

406,100,916

 

Derivative financial instruments

 

43,987

 

265,265

 

Current income tax liabilities

2,678,372

 

2,234,985

 

Other liabilities

19

9,945,543

 

8,021,310

 

Issued debt instruments

20

1,940,240

 

1,557,263

 

Other loans

 

6,257,126

 

5,140,782

 

Other Provisions

21

5,675,006

 

3,539,676

 

Total liabilities

 

525,828,748

 

427,722,956

 

Equity

 

 

 

 

Issued and paid up capital

26

29,825,134

 

19,702,418

 

Reserves

20,381,196

 

33,767,423

 

Reserve for employee stock ownership plan (ESOP)

 

1,751,123

 

1,674,392

 

Retained earnings *

 

12,573,600

 

13,783,935

 

Total equity and net profit for the period / year

 

64,531,053

 

68,928,168

 

Total liabilities and equity

 

590,359,801

 

496,651,124

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

(Review report attached)

 

 

*Including net profit for the current period

 

 

 

 

 

 

Hussein Abaza

Sherif Samy

 

CEO & Managing Director

Chairman

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Income Statement for the period ended September 30, 2022

 

 

 

 

 

 

Last 9 Months

Last 9 Months

 

 

Notes

 

Sep. 30, 2022

 

Sep. 30, 2021

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

Interest and similar income

38,761,627

 

32,568,923

 

Interest and similar expense

(17,050,977)

 

(14,463,322)

 

Net interest income

21,710,650

 

18,105,601

 

 

 

 

 

Fee and commission income

3,900,488

 

2,895,435

 

Fee and commission expense

(1,730,066)

 

(1,129,866)

 

Net fee and commission income

2,170,422

 

1,765,569

 

 

 

 

 

Dividends income

 

64,372

 

82,426

 

Net trading income

5

 

1,431,729

 

484,774

 

Profits (Losses) on financial investments

13

 

1,096,850

 

634,108

 

Administrative expenses

 

(5,024,897)

 

(4,382,463)

 

Other operating (expenses) income

6

(3,399,057)

 

(1,366,178)

 

Impairment release (charges) for credit losses

 

 

(262,606)

 

(1,325,770)

 

Profit before income tax

 

17,787,463

 

13,998,067

 

 

 

 

 

Income tax expense

25

(4,984,283)

 

(4,115,227)

 

Deferred tax assets (Liabilities)

25

(597,258)

 

11,845

 

Net profit for the period

 

12,205,922

 

9,894,685

 

 

 

 

 

Earning per share

7

 

 

 

Basic

3.62

 

2.97

 

Diluted

3.60

 

2.95

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

CEO & Managing Director

 

Sherif Samy

 

Chairman

 

 

 

 

 

Condensed Separate Interim Statement of Comprehensive Income for the period ended September 30, 2022

 

 

 

 

 

Last 9 Months

 

Last 9 Months

 

Sep. 30, 2022

 

Sep. 30, 2021

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

Net profit for the period

12,205,922

 

9,894,685

 

 

 

 

Change in fair value of financial instruments measured at fair value through other comprehensive income after income tax

(13,128,801)

 

(2,374,495)

 

Transferred to RE from financial assets at fair value through OCI

(4,128)

 

(177,362)

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

233,717

 

(98,246)

 

Total comprehensive income for the period

(693,290)

 

7,244,582

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Cash Flows for the period ended September 30, 2022

 

 

 

 

 

 

 

 

Notes

Sep. 30, 2022

 

Sep. 30, 2021

EGP Thousands

 

EGP Thousands

 

 

Cash flow from operating activities

 

 

Profit before income tax

17,787,463

 

13,998,067

Adjustments to reconcile profits to net cash provided by operating activities

 

 

Fixed assets depreciation

 

16

654,220

 

636,413

Impairment charge for credit losses (Loans and advances to customers and banks)

 

 

(16,255)

 

1,385,835

Other provisions charges

 

21

1,803,863

 

190,858

Impairment charge for credit losses (due from banks)

 

 

849

 

38,181

Impairment (Released) charge for credit losses (financial investments)

278,012

 

(98,246)

Impairment (Released) charge for other assets

(277,768)

 

31,975

Exchange revaluation differences for financial assets at fair value through OCI and AC

(3,745,045)

 

40,050

Utilization of other provisions

21

(1,857)

 

(44,978)

Other provisions no longer used

 

21

(101)

 

(12,255)

Exchange differences of other provisions

 

21

333,425

 

(13,722)

Losses (profits) from selling property and equipment

 

 

(2,192)

 

(2,124)

Losses (profits) from selling financial investments at fair value through OCI

 

13

(1,096,850)

 

(643,467)

Shares based payments

 

 

579,653

 

477,644

Impairment (Released) charges of investments in associates

 

 

-

 

9,359

Operating profits before changes in operating assets and liabilities

16,297,417

 

15,993,590

 

 

 

Net decrease (increase) in assets and liabilities

 

 

Due from banks

845,633

 

(272,238)

Financial assets at fair value through P&L

13

240,987

 

153,260

Derivative financial instruments

 

 

(947,116)

 

(24,448)

Loans and advances to banks and customers

 

11 - 12

(33,520,003)

 

(20,847,787)

Other assets

 

 

1,242,254

 

(1,631,518)

Due to banks

 

17

841,125

 

(7,272,811)

Due to customers

 

18

91,483,674

 

62,999,029

Current income tax obligations paid

 

 

(2,305,911)

 

(2,152,739)

Other liabilities

 

 

(310,752)

 

1,414,946

Net cash used in (generated from) operating activities

 

 

73,867,308

 

48,359,284

 

 

 

 

 

Cash flow from investing activities

 

 

Payments for investment in subsidiaries and associates.

(59,900)

 

(158,360)

Payment for purchases of property, equipment and branches constructions

(542,743)

 

(669,801)

Proceeds from selling property and equipment

2,192

 

2,124

Proceeds from redemption of financial assets at amortized cost

6,569,803

 

4,725,376

Payment for purchases of financial assets at amortized cost

(18,239,332)

 

(3,844)

Payment for purchases of financial assets at fair value through OCI

(114,918,927)

 

(207,918,546)

Proceeds from selling financial assets at fair value through OCI

73,463,225

 

146,303,855

Net cash generated from (used in) investing activities

(53,725,682)

 

(57,719,196)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Cash Flows for the period ended September 30, 2022 (Cont.)

 

 

Sep. 30, 2022

 

Sep. 30, 2021

 

EGP Thousands

 

EGP Thousands

 

 

 

 

Cash flow from financing activities

 

 

 

Other loans

1,116,344

 

(2,113,845)

 

Dividends paid

(4,410,322)

 

(1,360,652)

 

Issued debt instruments

382,977

 

1,556,032

 

Capital increase

122,716

 

-

 

Net cash generated from (used in) financing activities

(2,788,285)

 

(1,918,465)

 

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalent during the period

17,353,341

 

(11,278,377)

 

Beginning balance of cash and cash equivalent

60,891,899

 

75,965,247

 

Cash and cash equivalent at the end of the period

78,245,240

 

64,686,870

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

Cash and balances at the central bank

43,776,754

 

33,207,606

 

Due from banks

90,419,482

 

72,015,406

 

Treasury bills and other governmental notes

10

87,119,766

 

65,654,913

 

Obligatory reserve balance with CBE

 

(38,022,832)

 

(27,183,002)

 

Due from banks with maturities more than three months

(22,949,758)

 

(16,980,376)

 

Treasury bills with maturity more than three months

(82,098,172)

 

(62,027,677)

 

Total cash and cash equivalent

78,245,240

 

64,686,870

 

'

 

 

 

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended September 30, 2021

 

 

Sep. 30, 2021

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

EGP Thousands

Beginning balance

14,776,813

2,778,135

24,765,658

1,549,445

14,906

3,970,987

6,423

10,477,611

1,064,648

59,404,626

Capital increase

4,925,605

-

(4,925,605)

-

-

-

-

-

-

-

Transferred to reserves

-

514,939

8,420,479

-

1,094

-

-

(8,936,512)

-

-

Dividend paid

-

-

-

-

-

-

-

(1,360,652)

-

(1,360,652)

Net profit of the period

-

-

-

-

-

-

-

9,894,685

-

9,894,685

Transferred from reserve of financial assets at fair value through OCI

-

-

-

-

-

(177,362)

-

177,362

-

-

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

8,333

-

8,333

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(2,374,495)

-

-

-

(2,374,495)

Transferred (from) to bank risk reserve

-

-

-

-

-

-

2,718

(2,718)

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

(98,246)

-

-

-

(98,246)

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

477,644

477,644

Ending balance

19,702,418

3,293,074

28,260,532

1,549,445

16,000

1,320,884

9,141

10,258,109

1,542,292

65,951,895

Condensed Separate Interim statement of changes in shareholders' equity for the period ended September 30, 2022

 

 

 

 

Sep. 30, 2022

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

EGP Thousands

 

Beginning balance

19,702,418

3,293,074

28,260,532

1,549,445

16,000

639,231

9,141

13,783,935

1,674,392

68,928,168

 

 

 

 

Capital increase

10,122,716

-

(10,000,000)

-

-

-

-

-

-

122,716

 

 

 

 

Transferred to reserves

-

670,872

8,836,326

-

2,947

-

-

(9,007,223)

(502,922)

-

 

 

 

 

Dividend paid

-

-

-

-

-

-

-

(4,410,322)

-

(4,410,322)

 

 

 

 

Net profit of the period

-

-

-

-

-

-

-

12,205,922

-

12,205,922

 

 

 

 

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

(4,128)

-

4,128

-

-

 

 

 

 

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

-

-

-

 

 

 

 

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(13,128,801)

-

-

-

(13,128,801)

 

 

 

 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

2,840

(2,840)

-

-

 

 

 

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

233,717

-

-

-

233,717

 

 

 

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

579,653

579,653

 

 

 

 

Ending balance

29,825,134

3,963,946

27,096,858

1,549,445

18,947

(12,259,981)

11,981

12,573,600

1,751,123

64,531,053

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTFLFSALELVIIF
Date   Source Headline
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
20th Feb 20247:00 amRNSNotice of AGM
20th Feb 20247:00 amRNSInvitation to Extraordinary GM (EGM)
16th Nov 20233:45 pmRNSCIB secures a USD 150M subordinated loan from EBRD
3rd Nov 20237:05 amRNS3Q23 Earnings Release
3rd Nov 20237:05 amRNS3rd Quarter Results
3rd Nov 20237:05 amRNS3rd Quarter Results - Consolidated
23rd Aug 20237:14 amRNSAppointment of Mr. Jawaid Mirza in CIB's BOD
24th Jul 20238:00 amRNSCIB 1H2023 Earnings Release
24th Jul 20238:00 amRNSCIB1H2023 Condensed Consolidated Financials
24th Jul 20238:00 amRNSCIB 1H2023 Separate Condensed Financial Statements
10th Jul 20238:00 amRNSCIB obtaining Long term loans from IFC
15th May 20237:00 amRNSCIB 1Q23 - Earnings Release
15th May 20237:00 amRNSCIB Q1-2023 Separate Financial Statements
15th May 20237:00 amRNSCIB 1Q23 Consolidated Financial Statements
20th Mar 20236:26 pmRNSCIB's FY22 IFRS 9 Financial Statements
20th Mar 20235:02 pmRNSResolutions Extraordinary General Assembly
20th Mar 20234:55 pmRNSResolutions Ordinary General Assembly (OGM)
16th Feb 20237:00 amRNSInvitation to CIB's Ordinary General Assembly
16th Feb 20237:00 amRNSInvitation to CIB's Extraordinary General Assembly
13th Feb 20237:00 amRNSCIB - 4Q 2022 Earnings Release
13th Feb 20237:00 amRNSCIB Q4-2022 Separate Financial Statements
13th Feb 20237:00 amRNSCIB Q4-2022 Consolidated Financial Statements
30th Jan 20237:00 amRNSCIB fully acquires MayFair CIB (Kenya)-Replacement
27th Jan 20235:51 pmRNSCIB fully acquires Mayfair CIB
11th Jan 20234:41 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
8th Dec 202212:25 pmRNSPress Release dated 8 December 2022
22nd Nov 20228:14 amRNSChanges in CIB's Board of Directors
4th Nov 20227:00 amRNS3rd Quarter 2022 (Earnings Release)
4th Nov 20227:00 amRNSBoard Resolutions Summary 3 Nov 2022
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Separate)
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Consolidated)
15th Aug 20227:00 amRNSChange in CIB's CEO Retail Banking
25th Jul 20227:00 amRNSCIB 1H2022 Condensed Separate Financial Results
25th Jul 20227:00 amRNSCIB1H2022 Earnings Release
25th Jul 20227:00 amRNSCIB1H2022 Consolidated Condensed Financial Results
19th May 20223:09 pmRNSChange in CIB's Board of Directors
29th Apr 202212:17 pmRNSCIB FY 2021 IFRS Annual Financial Report
19th Apr 20227:00 amRNSCIB 1Q2022 Earnings Release
19th Apr 20227:00 amRNSCIB1Q2022 Condensed Consolidated Financial results
19th Apr 20227:00 amRNSCIB 1Q2022 Condensed Separate Results
28th Mar 20227:00 amRNSCIB's AGM Resolutions Summary
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSInvitation toCIB Ordinary General Assembly Meeting
22nd Feb 20227:00 amRNSCIB FY 2021 Separate Financial results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.